NO964965L - Fremgangsmåte ved fremstilling av proteiner - Google Patents
Fremgangsmåte ved fremstilling av proteinerInfo
- Publication number
- NO964965L NO964965L NO964965A NO964965A NO964965L NO 964965 L NO964965 L NO 964965L NO 964965 A NO964965 A NO 964965A NO 964965 A NO964965 A NO 964965A NO 964965 L NO964965 L NO 964965L
- Authority
- NO
- Norway
- Prior art keywords
- protein
- pro
- solid support
- proteins
- above process
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6429—Thrombin (3.4.21.5)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6432—Coagulation factor Xa (3.4.21.6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21005—Thrombin (3.4.21.5)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21006—Coagulation factor Xa (3.4.21.6)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT0192795A AT404597B (de) | 1995-11-24 | 1995-11-24 | Verfahren zur herstellung von proteinen |
Publications (3)
Publication Number | Publication Date |
---|---|
NO964965D0 NO964965D0 (no) | 1996-11-22 |
NO964965L true NO964965L (no) | 1997-05-26 |
NO319266B1 NO319266B1 (no) | 2005-07-11 |
Family
ID=3524033
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO19964965A NO319266B1 (no) | 1995-11-24 | 1996-11-22 | Fremgangsmate ved fremstilling og utvinning av proteiner fra pro-proteiner i ett fremgangsmatetrinn samt anvendelse av fremgangsmaten til fremstilling av proteiner. |
Country Status (7)
Country | Link |
---|---|
US (1) | US6010844A (no) |
EP (1) | EP0776969B1 (no) |
JP (1) | JP4180671B2 (no) |
AT (2) | AT404597B (no) |
CA (1) | CA2190802C (no) |
DE (1) | DE59611093D1 (no) |
NO (1) | NO319266B1 (no) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATA159597A (de) * | 1997-09-19 | 2000-09-15 | Immuno Ag | Präparat zur behandlung von blutgerinnungsstörungen |
US7560622B2 (en) * | 2000-10-06 | 2009-07-14 | Pioneer Hi-Bred International, Inc. | Methods and compositions relating to the generation of partially transgenic organisms |
US6830917B2 (en) | 2001-12-10 | 2004-12-14 | Baxter Healthcare S.A. | Method of isolation and purification of trypsin from pronase protease and use thereof |
US7235655B2 (en) * | 2002-03-22 | 2007-06-26 | Pharmacia & Upjohn Company | Processes to prepare eplerenone |
CA2558811A1 (en) | 2004-03-08 | 2005-09-22 | Zymogenetics, Inc. | Dimeric fusion proteins and materials and methods for producing them |
JP2012050387A (ja) * | 2010-09-01 | 2012-03-15 | Kaneka Corp | 2種類以上の分子を多孔質担体に固定化する方法 |
JP2012050386A (ja) * | 2010-09-01 | 2012-03-15 | Kaneka Corp | 2種類以上の多孔質充填剤を充填するカラム |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5053453A (en) * | 1988-11-01 | 1991-10-01 | Baxter International Inc. | Thromboresistant materials and methods for making same |
CA2000887A1 (en) * | 1988-11-01 | 1990-05-01 | Cecilia S.L. Ku | Thromboresistant materials and methods for making same |
DE3843126C3 (de) * | 1988-12-22 | 1994-10-06 | Octapharma Ag | Verfahren zur Herstellung eines hochreinen Thrombinkonzentrates |
HU905784D0 (en) | 1989-09-05 | 1991-03-28 | Lilly Co Eli | Process for activating protein c |
US5296352A (en) * | 1990-10-02 | 1994-03-22 | Ciba-Geigy Corporation | Monoclonal antibodies directed against complexes formed by thrombin and hirudin |
AT398079B (de) | 1991-11-04 | 1994-09-26 | Immuno Ag | Präparation mit thrombinaktivität sowie verfahren zu ihrer herstellung |
AT396937B (de) * | 1992-04-06 | 1993-12-27 | Immuno Ag | Verfahren zur aktivierung von blutgerinnungsfaktoren |
AT397390B (de) | 1992-04-06 | 1994-03-25 | Immuno Ag | Verfahren zur spaltung von proteinen |
-
1995
- 1995-11-24 AT AT0192795A patent/AT404597B/de not_active IP Right Cessation
-
1996
- 1996-11-19 AT AT96890172T patent/ATE277169T1/de active
- 1996-11-19 DE DE59611093T patent/DE59611093D1/de not_active Expired - Lifetime
- 1996-11-19 EP EP96890172A patent/EP0776969B1/de not_active Expired - Lifetime
- 1996-11-20 US US08/752,892 patent/US6010844A/en not_active Expired - Lifetime
- 1996-11-20 CA CA002190802A patent/CA2190802C/en not_active Expired - Fee Related
- 1996-11-22 NO NO19964965A patent/NO319266B1/no not_active IP Right Cessation
- 1996-11-25 JP JP33027896A patent/JP4180671B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP0776969A3 (de) | 1999-06-02 |
JP4180671B2 (ja) | 2008-11-12 |
CA2190802C (en) | 2008-02-12 |
CA2190802A1 (en) | 1997-05-25 |
AT404597B (de) | 1998-12-28 |
EP0776969B1 (de) | 2004-09-22 |
EP0776969A2 (de) | 1997-06-04 |
NO964965D0 (no) | 1996-11-22 |
JPH09183794A (ja) | 1997-07-15 |
US6010844A (en) | 2000-01-04 |
ATE277169T1 (de) | 2004-10-15 |
NO319266B1 (no) | 2005-07-11 |
DE59611093D1 (de) | 2004-10-28 |
ATA192795A (de) | 1998-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU4155989A (en) | Removal of process chemicals from labile biological mixtures by hydrophobic interaction chromatography | |
AU638133B2 (en) | Ribosome inactivating proteins, inactive precursor forms thereof, a process for making and a method of using | |
EP0322687A3 (en) | Method for the manufacture of a product having at least one substance embedded in a carrier | |
NO964965D0 (no) | Fremgangsmåte ved fremstilling av proteiner | |
SE8302638L (sv) | Forfarande och anordning for utvinning av en forening | |
KR970009949B1 (en) | Novel serine proteolytic enzyme and its process | |
HUT63863A (en) | Complex comprising anticoagulant ix factor | |
WO1996009547A3 (de) | Verfahren zur untersuchung der wechselwirkung von biomolekülen mittels oberflächen-plasmon-resonanz | |
FI915813A0 (fi) | Menetelmä luonnollisesti tuotetun kymosiinin talteenottamiseksi | |
AU7199796A (en) | Process for removing aromatic compounds from product- containing solutions | |
ATE270327T1 (de) | Verfahren zur präparation von humanem aktiviertem protein c | |
DE3855002D1 (de) | Verfahren zur Herstellung von Dodecahydro-3a,6,6,9a-tetramethylnaphto(2,1-b)furan | |
ATE216778T1 (de) | Verfahren zur herstellung von konjugaten aus einem spezifischen bindungspartner und einem kohlenhydrathaltigen protein | |
DE3668185D1 (de) | Verfahren zur reinigung von plasminogenaktivatoren (pa). | |
AU9075682A (en) | Immobilised protease | |
DK0379887T3 (da) | Immunobestemmelse til cellulære proteiner | |
FI854373A (fi) | Anordning foer behandling av roekgaser som en produkt i form av pulver. | |
EP0345812A3 (en) | Process utilizing alcohol oxidase | |
AU1062588A (en) | Immunoassay utilizing microparticle neutralization | |
EP0276008A3 (en) | Fibrin-specific antibody, method for its production and its use | |
DK0846166T3 (da) | Fremgangsmåde til thrombinfremstilling | |
HUT49151A (en) | Process for production of biotinilated proteins |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
CHAD | Change of the owner's name or address (par. 44 patent law, par. patentforskriften) |
Owner name: BAXALTA INCORPORATED, CH |
|
MK1K | Patent expired |